Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002341171 | SCV002640903 | pathogenic | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2021-07-01 | criteria provided, single submitter | clinical testing | The c.4935dupT pathogenic mutation, located in coding exon 36 of the NF1 gene, results from a duplication of T at nucleotide position 4935, causing a translational frameshift with a predicted alternate stop codon (p.P1646Sfs*15). This alteration was identified once in a cohort of patients affected with Neurofibromatosis Type 1 (Bonatti F et al. Int J Mol Sci, 2017 Sep;18:). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Medical Genetics, |
RCV000497219 | SCV000588794 | pathogenic | Neurofibromatosis, type 1 | 2017-02-02 | no assertion criteria provided | clinical testing |